Mercer Capital Advisers’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-168
Closed -$22K – 215
2019
Q1
$22K Hold
168
– – 0.01% 173
2018
Q4
$18K Hold
168
– – 0.01% 179
2018
Q3
$25K Hold
168
– – 0.02% 170
2018
Q2
$26K Hold
168
– – 0.02% 174
2018
Q1
$23K Hold
168
– – 0.02% 176
2017
Q4
$23K Hold
168
– – 0.02% 181
2017
Q3
$22K Hold
168
– – 0.02% 187
2017
Q2
$22K Hold
168
– – 0.02% 194
2017
Q1
$21K Hold
168
– – 0.02% 198
2016
Q4
$18K Hold
168
– – 0.01% 203
2016
Q3
$20K Hold
168
– – 0.02% 211
2016
Q2
$19K Hold
168
– – 0.02% 211
2016
Q1
$17K Hold
168
– – 0.01% 212
2015
Q4
$18K Hold
168
– – 0.02% 218
2015
Q3
$16K Hold
168
– – 0.01% 217
2015
Q2
$17K Hold
168
– – 0.02% 230
2015
Q1
$18K Buy
+168
New +$17.3K 0.02% 222

Other funds holding LH

Mercer Capital Advisers's LH Position: Q2 2019 in Review

Mercer Capital Advisers sold out of Labcorp (LH) in Q2 2019, closing a stake of 168 shares — an estimated $22K sold.

Mercer Capital Advisers first reported a position in LH in Q1 2015 and held it in 17 quarters. The position peaked at $26K in Q2 2018. 741 funds tracked by Wall St. Rank hold LH as of Q2 2019.

  • Mercer Capital Advisers reported no remaining Labcorp position as of Q2 2019 after selling out during the quarter.
  • Mercer Capital Advisers sold 168 Labcorp shares in Q2 2019, an estimated $22K.
  • Mercer Capital Advisers first reported a position in Labcorp in Q1 2015 and held it in 17 quarters.
  • Mercer Capital Advisers's Labcorp position peaked at $26K in Q2 2018.
  • 741 funds tracked by Wall St. Rank held Labcorp as of Q2 2019.

Based on Mercer Capital Advisers's 13F filing for Q2 2019, filed 24 Jul 2019.